Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction

Stem Cell Research and Therapy

Volumn 5, Issue 2, 2014, Pages

  Zhao, Shu Li ^a,b   Zhang, Yao Jun ^a,c   Li, Ming Hui ^a   Zhang, Xin Lei ^a   Chen, Shao Liang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; MIDKINE; PHOSPHATE BUFFERED SALINE; PLASMID VECTOR; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL HYPOXIA; CELL ISOLATION; CELL MIGRATION; CELL PROTECTION; CELL STRAIN; CELL STRAIN H9C2; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE MODEL; ECHOCARDIOGRAPHY; FEMALE; GENE CONSTRUCT; GENE OVEREXPRESSION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MK GENE; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SURVIVAL RATE; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899088403     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt425     Document Type: Article

References (35)

1. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. Herzog CA, Ma JZ, Collins AJ, N Engl J Med 1998 339 799 805 10.1056/NEJM199809173391203 9738087
2. Apoptosis in heart failure. Sabbah HN, Sharov VG, Prog Cardiovasc Dis 1998 40 549 562 10.1016/S0033-0620(98)80003-0 9647609
3. Remodeling in the ischemic heart: the stepwise progression for heart failure. Mill JG, Stefanon I, dos Santos L, Baldo MP, Braz J Med Biol Res 2011 44 890 898 10.1590/S0100-879X2011007500096 21829898
4. Role of apoptosis in remodeling after myocardial infarction. Takemura G, Fujiwara H, Pharmacol Ther 2004 104 1 16 10.1016/j.pharmthera.2004.07.005 15500905
5. Cardiac repair with allogeneic mesenchymal stem cells after myocardial infarction. Vassalli G, Moccetti T, Swiss Med Wkly 2011 141 13209 21607881
6. Mesenchymal stem cells for the treatment of heart failure. Ohnishi S, Ohgushi H, Kitamura S, Nagaya N, Int J Hematol 2007 86 17 21 10.1532/IJH97.07041 17675261
7. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Chen S, Fang W, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP, Am J Cardiol 2004 94 92 95 10.1016/j.amjcard.2004.03. 034 15219514
8. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, Zhang JJ, Lin S, Liao LM, Zhao RC, Chin Med J (Engl) 2004 117 1443 1448 Erratum in Chin Med J (Engl) 2005, 118: 88 15498362
9. Lessons from genetically altered mesenchymal stem cells (MSCs): candidates for improved MSC-directed myocardial repair. Alfaro MP, Young PP, Cell Transplant 2012 21 1065 1074 10.3727/096368911X612477 22080676
10. Generation of mesenchymal stem cells as a medicinal product in organ transplantation. Verbeek R, Curr Opin Organ Transplant 2013 18 65 70 10.1097/MOT.0b013e32835c2998 23222173
11. Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling. Williams AR, Suncion VY, McCall F, Guerra D, Mather J, Zambrano JP, Heldman AW, Hare JM, J Am Heart Assoc 2013 2 000140 23686370
12. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function. Houtgraaf JH, de Jong R, Kazemi K, de Groot D, van der Spoel TI, Arslan F, Hoefer I, Pasterkamp G, Itescu S, Zijlstra F, Geleijnse ML, Serruys PW, Duckers HJ, Circ Res 2013 113 153 166 10.1161/CIRCRESAHA.112.300730 23658436
13. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Forest VF, Tirouvanziam AM, Perigaud C, Fernandes S, Fusellier MS, Desfontis JC, Toquet CS, Heymann MF, Crochet DP, Lemarchand PF, Stem Cell Res Ther 2010 1 4 10.1186/scrt4 20504285
14. Midkine and pleiotrophin in neural development and cancer. Kadomatsu K, Muramatsu T, Cancer Lett 2004 204 127 143 10.1016/S0304-3835(03)00450-6 15013213
15. Neointima formation in a restenosis model is suppressed in midkine-deficient mice. Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S, Hayashi K, Yuzawa Y, Saito H, Muramatsu T, J Clin Invest 2000 87 489 495
16. Myocardial infarction induces expression of midkine, a heparin-binding growth factor with reparative activity. Obama H, Biro S, Tashiro T, Tsutsui J, Ozawa M, Yoshida H, Tanaka H, Muramatsu T, Anticancer Res 1998 18 145 152 9568069
17. Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Horiba M, Kadomatsu K, Yasui K, Lee J-K, Takenaka H, Sumida A, Kamiya K, Chen S, Sakuma S, Muramatsu T, Kodama I, Circulation 2006 114 1713 1720 10.1161/CIRCULATIONAHA.106.632273 17015789
18. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. Takenaka H, Horiba M, Ishiguro H, Sumida A, Hojo M, Usui A, Akita T, Sakuma S, Ueda Y, Kodama I, Kadomatsu K, Am J Physiol Heart Circ Physiol 2009 296 462 469
19. Therapeutic effect of midkine on cardiac remodeling in infarcted rat heart. Fukui S, Kitagawa-Sakakida S, Kawamata S, Matsumiya G, Kawaguchi N, Matsuura N, Sawa Y, Ann Thorac Surg 2008 85 562 570 10.1016/j.athoracsur.2007. 06.002 18222265
20. Midkine prevented hypoxic injury of mouse embryonic stem cells through activation of Akt and HIF-1α via low-density lipoprotein receptor-related protein-1. Lee SH, Suh HN, Lee YJ, Seo BN, Ha JW, Han HJ, J Cell Physiol 2012 227 1731 1739 10.1002/jcp.22897 21688265
21. Optimization of genetic engineering and homologous recombination of collagen type I genes in rat bone marrow mesenchymal stem cells (MSC). Tarnowski M, Szydło A, Anioł J, Koryciak-Komarska H, Lesiak M, Gutmajster E, Sieroń AL, Kusz D, Cell Reprogram 2010 12 275 282 10.1089/cell.2009. 0084 20698769
22. Intramyocardial delivery of mesenchymal stem cell seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. Mathieu E, Lamirault G, Toquet C, Lhommet P, Rederstorff E, Sourice S, Biteau K, Hulin P, Forest V, Weiss P, Guicheux J, Lemarchand P, PLoS One 2012 7 51991 10.1371/journal.pone.0051991 23284842
23. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA). Liu RS, Hsieh YJ, Ke CC, Chen FD, Hwu L, Wang FH, Hwang JJ, Chi CW, Lee CH, Yeh SH, Anticancer Res 2009 29 211 222 19331152
24. Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells. Sanchez-Antequera Y, Mykhaylyk O, van Til NP, Cengizeroglu A, de Jong JH, Huston MW, Anton M, Johnston IC, Pojda Z, Wagemaker G, Plank C, Blood 2011 117 171 e181 10.1182/blood-2010-08-302646 21357765
25. Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. Xiang J, Tang J, Song C, Yang Z, Hirst DG, Zheng QJ, Li G, Cytotherapy 2009 11 516 526 10.1080/14653240902960429 19562576
26. Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity. Zhao S, Wang H, Nie Y, Mi Q, Chen X, Hou Y, Cancer Immunol Immunother 2012 61 1745 1753 10.1007/s00262-012-1235-3 22415659
27. Protective effect of 20-HETE inhibition in a model of oxygen-glucose deprivation in hippocampal slice cultures. Renic M, Kumar SN, Gebremedhin D, Florence MA, Gerges NZ, Falck JR, Harder DR, Roman RJ, Am J Physiol Heart Circ Physiol 2012 302 1285 H1293 10.1152/ajpheart.00340.2011 22245774
28. Cardioprotective effects of 3-phosphoinositide-dependent protein kinase-1 on hypoxic injury in cultured neonatal rat cardiomyocytes and myocardium in a rat myocardial infarct model. Shim TJ, Bae JW, Kim YJ, Kim DJ, Hwang KK, Kim DW, Cho MC, Biosci Biotechnol Biochem 2012 76 101 107 10.1271/bbb.110562 22232248
29. Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. Khan M, Mohsin S, Khan SN, Riazuddin S, J Cell Mol Med 2011 15 1515 1527 10.1111/j.1582-4934.2009.00998.x 20041970
30. Morphological, molecular and functional differences of adult bone marrow- and adipose-derived stem cells isolated from rats of different ages. Mantovani C, Raimondo S, Haneef MS, Geuna S, Terenghi G, Shawcross SG, Wiberg M, Exp Cell Res 2012 318 2034 2048 10.1016/j.yexcr.2012.05.008 22659169
31. Intramyocardial delivery of mesenchymal stem cell seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. Mathieu E, Lamirault G, Toquet C, Lhommet P, Rederstorff E, Sourice S, Biteau K, Hulin P, Forest V, Weiss P, Guicheux J, Lemarchand P, PLoS One 2012 7 51991 10.1371/journal.pone.0051991 23284842
32. Mesenchymal stem cell therapy for heart disease. Gnecchi M, Danieli P, Cervio E, Vascul Pharmacol 2012 57 48 55 10.1016/j.vph.2012.04.002 22521741
33. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ, Nat Med 2003 9 1195 1201 10.1038/nm912 12910262
34. Promotion of self-renewal of embryonic stem cells by midkine. Yao X, Tan Z, Bin G, Rong-rong W, Liu Y, Dai L, Zhang M, Acta Pharmacol Sin 2010 31 629 637 10.1038/aps.2010.39 20442752
35. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D, Science 1996 272 263 267 10.1126/science.272.5259.263 8602510